Mediphore
Interoperability. Solved.
New York, NY, United States
Mediphore enhances healthcare process efficiency by re-engineering medical workflows, not just data. Their proven, patented technology delivers solutions via an interoperable, non-disruptive, seamless, HIPAA & GDPR compliant platform, delivering a holistic patient journey across hospital networks and coordinating virtual care.
How We Help
Photos & Videos
Previous logo
Problem Statement
Healthcare systems suffer from significant process inefficiencies and a lack of data interoperability. This leads to fragmented patient records, delays in care, and difficulties in coordinating across different providers and systems, ultimately increasing costs and risks.
Core Technology
Patented Process Interoperability Platform (PIPCO) and Intelligent Meta PACS system (IMPACS)
Key Differentiators
- True Interoperability: Convert and deliver patient records in any format. - Master Patient Identifier: Unify patient records into a single comprehensive view. - Swift Transmission: Deliver records to any legacy system. - Simplified Logistics: Delivers records without needing to locate each one individually. - Version Control: Provides up-to-date comprehensive medical histories.
Target Customers
Hospital Systems, Virtual Care Providers, Medical Imaging Centers, Insurance Companies, Public Health Organizations
Company Info
- Business Model
- B2B Platform
- Founded
- 2018
- Website
- www.mediphore.com
Categories
Technologies
Clinical & IP
Clinical Validation
3 Granted Patents: U.S. Patent No. 10,810,550, EU Patent No. 3 891 690, U.S. Patent No. 12,020,803. Serving one of the largest hospital networks in India since August 2023. Collaboration with a leading US oncology center established November 2023.
IP Protection
patents granted
Only accessible to MedStartr community members.
Join nowWhat do you think of Mediphore?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.